IDO1 and neoplasm: Using a murine model, Uyttenhove et al. showed that a tumor with elevated IDO1 activity was not detected nor destroyed by tumor-specific host immune cells [11]—a phenomenon shown to result from tryptophan (TRP) depletion by the IDO1-expressing tumor.